Cargando…

Lessons We Have Learned Regarding Seroprevalence in High and Low SARS-CoV-2 Contexts in Greece before the Omicron Pandemic Wave

Background: Antibody seroprevalence in rural communities remains poorly investigated. We compared the SARS-CoV-2 seroprevalence in two Greek communities in June and July 2021 after the end of the Delta-driven pandemic wave that started in November 2020. One community was affected worse than the othe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotsiou, Ourania S., Vavougios, George D., Papagiannis, Dimitrios, Matsiatsiou, Elena, Avgeri, Dimitra, Fradelos, Evangelos C., Siachpazidou, Dimitra I., Perlepe, Garifallia, Miziou, Angeliki, Kyritsis, Athanasios, Gogou, Eudoxia, Kalampokas, Serafim, Kalantzis, Georgios, Kotsios, Vaios S., Gourgoulianis, Konstantinos I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140933/
https://www.ncbi.nlm.nih.gov/pubmed/35627648
http://dx.doi.org/10.3390/ijerph19106110
_version_ 1784715220825931776
author Kotsiou, Ourania S.
Vavougios, George D.
Papagiannis, Dimitrios
Matsiatsiou, Elena
Avgeri, Dimitra
Fradelos, Evangelos C.
Siachpazidou, Dimitra I.
Perlepe, Garifallia
Miziou, Angeliki
Kyritsis, Athanasios
Gogou, Eudoxia
Kalampokas, Serafim
Kalantzis, Georgios
Kotsios, Vaios S.
Gourgoulianis, Konstantinos I.
author_facet Kotsiou, Ourania S.
Vavougios, George D.
Papagiannis, Dimitrios
Matsiatsiou, Elena
Avgeri, Dimitra
Fradelos, Evangelos C.
Siachpazidou, Dimitra I.
Perlepe, Garifallia
Miziou, Angeliki
Kyritsis, Athanasios
Gogou, Eudoxia
Kalampokas, Serafim
Kalantzis, Georgios
Kotsios, Vaios S.
Gourgoulianis, Konstantinos I.
author_sort Kotsiou, Ourania S.
collection PubMed
description Background: Antibody seroprevalence in rural communities remains poorly investigated. We compared the SARS-CoV-2 seroprevalence in two Greek communities in June and July 2021 after the end of the Delta-driven pandemic wave that started in November 2020. One community was affected worse than the other. Methods: The SARS-CoV-2 IgG II Quant method (Architect, Abbott, IL, USA) was used for antibody testing. Results: We found a high rate of SARS-CoV-2 seropositivity in both communities, approaching 77.5%. In the area with a higher burden of COVID-19, Malesina, seropositivity was achieved with vaccine-acquired and naturally acquired immunity, whereas in the low-burden context of Domokos, the high rates of seropositivity were achieved mainly with vaccination. Previously infected individuals were less likely to be vaccinated than previously uninfected adults. The antibody titers were significantly higher in previously infected, vaccinated participants than in unvaccinated ones. In total, 4% and 10% of the unvaccinated population were diagnosed seropositive for the first time while not knowing about the previous infection. Age and gender did not impact antibody titers in high- or low-burden contexts. Conclusions: Before the Omicron pandemic wave, herd immunity was reached in different contexts in Greece. Higher antibody titers were measured in infected vaccinated individuals than in infected unvaccinated ones.
format Online
Article
Text
id pubmed-9140933
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91409332022-05-28 Lessons We Have Learned Regarding Seroprevalence in High and Low SARS-CoV-2 Contexts in Greece before the Omicron Pandemic Wave Kotsiou, Ourania S. Vavougios, George D. Papagiannis, Dimitrios Matsiatsiou, Elena Avgeri, Dimitra Fradelos, Evangelos C. Siachpazidou, Dimitra I. Perlepe, Garifallia Miziou, Angeliki Kyritsis, Athanasios Gogou, Eudoxia Kalampokas, Serafim Kalantzis, Georgios Kotsios, Vaios S. Gourgoulianis, Konstantinos I. Int J Environ Res Public Health Article Background: Antibody seroprevalence in rural communities remains poorly investigated. We compared the SARS-CoV-2 seroprevalence in two Greek communities in June and July 2021 after the end of the Delta-driven pandemic wave that started in November 2020. One community was affected worse than the other. Methods: The SARS-CoV-2 IgG II Quant method (Architect, Abbott, IL, USA) was used for antibody testing. Results: We found a high rate of SARS-CoV-2 seropositivity in both communities, approaching 77.5%. In the area with a higher burden of COVID-19, Malesina, seropositivity was achieved with vaccine-acquired and naturally acquired immunity, whereas in the low-burden context of Domokos, the high rates of seropositivity were achieved mainly with vaccination. Previously infected individuals were less likely to be vaccinated than previously uninfected adults. The antibody titers were significantly higher in previously infected, vaccinated participants than in unvaccinated ones. In total, 4% and 10% of the unvaccinated population were diagnosed seropositive for the first time while not knowing about the previous infection. Age and gender did not impact antibody titers in high- or low-burden contexts. Conclusions: Before the Omicron pandemic wave, herd immunity was reached in different contexts in Greece. Higher antibody titers were measured in infected vaccinated individuals than in infected unvaccinated ones. MDPI 2022-05-17 /pmc/articles/PMC9140933/ /pubmed/35627648 http://dx.doi.org/10.3390/ijerph19106110 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kotsiou, Ourania S.
Vavougios, George D.
Papagiannis, Dimitrios
Matsiatsiou, Elena
Avgeri, Dimitra
Fradelos, Evangelos C.
Siachpazidou, Dimitra I.
Perlepe, Garifallia
Miziou, Angeliki
Kyritsis, Athanasios
Gogou, Eudoxia
Kalampokas, Serafim
Kalantzis, Georgios
Kotsios, Vaios S.
Gourgoulianis, Konstantinos I.
Lessons We Have Learned Regarding Seroprevalence in High and Low SARS-CoV-2 Contexts in Greece before the Omicron Pandemic Wave
title Lessons We Have Learned Regarding Seroprevalence in High and Low SARS-CoV-2 Contexts in Greece before the Omicron Pandemic Wave
title_full Lessons We Have Learned Regarding Seroprevalence in High and Low SARS-CoV-2 Contexts in Greece before the Omicron Pandemic Wave
title_fullStr Lessons We Have Learned Regarding Seroprevalence in High and Low SARS-CoV-2 Contexts in Greece before the Omicron Pandemic Wave
title_full_unstemmed Lessons We Have Learned Regarding Seroprevalence in High and Low SARS-CoV-2 Contexts in Greece before the Omicron Pandemic Wave
title_short Lessons We Have Learned Regarding Seroprevalence in High and Low SARS-CoV-2 Contexts in Greece before the Omicron Pandemic Wave
title_sort lessons we have learned regarding seroprevalence in high and low sars-cov-2 contexts in greece before the omicron pandemic wave
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140933/
https://www.ncbi.nlm.nih.gov/pubmed/35627648
http://dx.doi.org/10.3390/ijerph19106110
work_keys_str_mv AT kotsiououranias lessonswehavelearnedregardingseroprevalenceinhighandlowsarscov2contextsingreecebeforetheomicronpandemicwave
AT vavougiosgeorged lessonswehavelearnedregardingseroprevalenceinhighandlowsarscov2contextsingreecebeforetheomicronpandemicwave
AT papagiannisdimitrios lessonswehavelearnedregardingseroprevalenceinhighandlowsarscov2contextsingreecebeforetheomicronpandemicwave
AT matsiatsiouelena lessonswehavelearnedregardingseroprevalenceinhighandlowsarscov2contextsingreecebeforetheomicronpandemicwave
AT avgeridimitra lessonswehavelearnedregardingseroprevalenceinhighandlowsarscov2contextsingreecebeforetheomicronpandemicwave
AT fradelosevangelosc lessonswehavelearnedregardingseroprevalenceinhighandlowsarscov2contextsingreecebeforetheomicronpandemicwave
AT siachpazidoudimitrai lessonswehavelearnedregardingseroprevalenceinhighandlowsarscov2contextsingreecebeforetheomicronpandemicwave
AT perlepegarifallia lessonswehavelearnedregardingseroprevalenceinhighandlowsarscov2contextsingreecebeforetheomicronpandemicwave
AT miziouangeliki lessonswehavelearnedregardingseroprevalenceinhighandlowsarscov2contextsingreecebeforetheomicronpandemicwave
AT kyritsisathanasios lessonswehavelearnedregardingseroprevalenceinhighandlowsarscov2contextsingreecebeforetheomicronpandemicwave
AT gogoueudoxia lessonswehavelearnedregardingseroprevalenceinhighandlowsarscov2contextsingreecebeforetheomicronpandemicwave
AT kalampokasserafim lessonswehavelearnedregardingseroprevalenceinhighandlowsarscov2contextsingreecebeforetheomicronpandemicwave
AT kalantzisgeorgios lessonswehavelearnedregardingseroprevalenceinhighandlowsarscov2contextsingreecebeforetheomicronpandemicwave
AT kotsiosvaioss lessonswehavelearnedregardingseroprevalenceinhighandlowsarscov2contextsingreecebeforetheomicronpandemicwave
AT gourgoulianiskonstantinosi lessonswehavelearnedregardingseroprevalenceinhighandlowsarscov2contextsingreecebeforetheomicronpandemicwave